Akoya生物科學公司（納斯達克代碼：AKYA）報告季度每股虧損$(0.17)，未能達到分析師共識預期的$(0.16)，差距爲6.25%。這比去年同期每股虧損$(0.22)增加了22.73%。公司報告季度銷售額爲$2134萬，符合分析師共識預期。與去年同期的銷售額$2649萬相比，下降了19.42%。

以上內容來自Benzinga Earnings專欄，原文如下：

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.16) by 6.25 percent. This is a 22.73 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $21.34 million which met the analyst consensus estimate. This is a 19.42 percent decrease over sales of $26.49 million the same period last year.